Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | C-CAR039 |
Trade Name | |
Synonyms | JNJ-90014496|JNJ90014496 |
Drug Descriptions |
C-CAR039 is a chimeric antigen receptor T cell (CAR-T) therapy that targets CD19 and CD20, potentially resulting in a decrease in tumor cells (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 2507). |
DrugClasses | CD19 Immune Cell Therapy 62 CD20 Immune Cell Therapy 11 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
C-CAR039 | C-CAR039 | 0 | 1 |